Posts Tagged ‘Restasis

Manufacturer: Allergan, Inc., Irvine, CA Indication: Treatment of keratoconjunctivitis sicca (chronic dry eye disease, or CDED) in patients whose tear production is suppressed because of eye inflammation Drug Class: This ophthalmic emulsion contains a topical immunomodulator with anti-inflammatory activity. Uniqueness of Drug: Cyclosporine ophthalmic emulsion increases tear production in patients with dry eyes who do […]

Manufacturer: Biogen, Inc., Cambridge, MA Indication: Alefacept is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy. Drug Class: Alefacept is an immunosuppressive, dimeric, fusion protein that consists of the extracellular CD2-binding portion of the human leukocyte function antigen-3 (LFA-3) linked to […]

Adalimumab (Humira™) Manufacturer: Abbott Laboratories, North Chicago, IL Indication: Treatment of rheumatoid arthritis (RA) Drug Class: Adalimumab is a recombinant human immunoglobulin G (IgG1) monoclonal antibody that is specific for human tumor necrosis factor (TNF). It was created using phage-display technology, resulting in an antibody with human-derived heavy chain and light chain variable regions and […]